Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,864,156
+$2,169,591 QoQ
Shares Held
25,287
+7.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#237
of 844 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $525,286,721 across 12 Diagnostics & Research names. NTRA ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
433,314 | $217,246,307 | |
| 2 | DHR |
Danaher Corp /De/
|
1,007,284 | $191,867,456 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
50,714 | $26,697,878 | |
| 4 | A |
Agilent Technologies, Inc.
|
133,237 | $17,697,870 | |
| 5 | WAT |
Waters Corp /De/
|
41,300 | $15,489,152 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
79,234 | $15,309,593 | |
| 7 | DGX |
Quest Diagnostics Inc
|
51,492 | $10,913,729 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
8,092 | $10,337,610 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,864,156 | 25,287 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,694,565 | 23,474 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,306,729 | 5,704 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $886,139 | 5,505 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $930,014 | 5,505 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $807,309 | 5,709 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||